Loading...
Loading...
Radient Pharmaceuticals Corporation (
RXPC) announced Tuesday that its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012 .
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in